Qiagen, a Nasdaq and Frankfurt-listed healthcare services provider, has acquired Ingenuity Systems, a US–based provider of software to analyse genomic data and has been backed by database company Oracle, for $105m in cash. Ingenuity Systems, which posted net sales of $20m last year, has raised money from a wide group of investors, including a $15.3m round in July 2010. Previously, it had more than $14m from venture capital firm 5AM Ventures, Accel Partners, Three Arch Partners, Bay City Capital, Morgan Stanley Capital Partners, Oracle Venture Fund, Millennium Pharmaceuticals, Affymetrix Corporation, according to news provider Fortune and other press reports. Ingenuity said its investors now included Accel, QuestMark, Rho, three Arch and secondaries firm Industry Ventures.

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?